TB: A partnership for the benefit of research and community

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 99, Issue SUPPL. 1, 2005, Pages 15-19

  Walzl, Gerhard ^a   Beyers, Nulda ^a   van Helden, Paul ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Epidemiological field site; Exogenous reinfection; Private public partnership; South Africa; Surrogate marker; Tuberculosis

Indexed keywords

TUBERCULOSTATIC AGENT;

ARTICLE; DIRECTLY OBSERVED THERAPY; DISEASE MARKER; DRUG MANUFACTURE; DRUG RESEARCH; ENDEMIC DISEASE; HUMAN; ORGANIZATION; POVERTY; PROGNOSIS; REINFECTION; RELAPSE; SHORT COURSE THERAPY; SOUTH AFRICA; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

EID: 23844513039     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2005.06.006     Document Type: Article

References (5)

1. City of Cape Town/Metropole Region, 2002. TB control programme progress report 1997-2002.
2. M. Richardson N.M. Carroll E. Engelke G.D. van der Spuy F. Salker Z. Munch R.P. Gie R.M. Warren N. Beyers P.D. van Helden Multiple Mycobacterium tuberculosis strains in early cultures from patients in a high-incidence community setting J. Clin. Microbiol. 40 2002 2750-2754
3. A. Van Rie R.M. Warren M. Richardson T.C. Victor R.P. Gie D.A. Enarson N. Beyers P.D. van Helden Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment New Engl. J. Med. 341 1999 1174-1179
4. R.M. Warren T.C. Victor E.M. Streicher M. Richardson N. Beyers N.C. van Pittius P.D. van Helden Patients with active tuberculosis often have different strains in the same sputum specimen Am. J. Respir. Crit. Care. Med. 169 2004 610-614
5. WHO, 2004. Global TB Control, 8th Annual Report. World Health Organization, Geneva.